Equifax Board of Directors Declares Quarterly Dividend
ATLANTA, May 2, 2024 /PRNewswire/ -- Equifax® (NYSE: EFX) today announced that the Equifax Board of Directors declared a quarterly dividend of $0.39 per share, payable on June 14, 2024, to shareholders of record as of the close of business on May 24, 2024. Equifax has paid cash dividends for more than 100 consecutive years.
ABOUT EQUIFAX INC. At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.
Battery Ventures, a global, technology-focused investment firm, announced it has closed its take-private acquisition of field-service workflow company TrueContext, formerly known as ProntoForms.
The Canadian software company was officially delisted...
Marti Technologies, Inc. ("Marti" or the "Company") , Türkiye's leading mobility super app, today announced that it has appointed Oguz Erkan as its new Chief Financial Officer ("CFO"), effective May 17, 2024. Oguz Erkan replaces the Company's former...
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...
Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of Kumar Gaurav Gupta as its new Chief Executive Officer (CEO). Taking on the role of CEO he shoulders the responsibility of propelling growth, with a...
The enterprise software market is one of the fastest-growing segments within the IT industry. A Statista report shows that it consistently experiences over 10% year-on-year growth...
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...
